Dark

DYN
Dyne Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Mar 6, 2026 2:59:02 PM EST

14.76USD-2.895%(-0.44)2,592,893

0.00Bid 0.00Ask 0.00Spread

Pre-market

Mar 3, 2026 8:28:30 AM EST

16.09USD+5.855%(+0.89)0

After-hours

Mar 6, 2026 4:00:30 PM EST

14.86USD+0.678%(+0.10)9,082

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.43B

Headquarters

Waltham, MA, USA

Industry

Biotechnology

Next Earnings

Apr 30, 2026 (52d)

AES CNP NRG ALE XLU

DYN Stats

Avg. Vol. 10 Day

2,121,422

Avg. Vol. 30 Day

1,936,146

Employees

2,489

Market Cap

2,434,383,309

Shares Out.

164,652,236

On/Off Exchange

57%/43%

6 Month Beta

2.31

1 Year Beta

1.58

2 Year Beta

1.76

3 Year Beta

1.68

52 Week Low

6.36

52 Week High

25.00

SMA50

17.23

SMA200

15.13

1 Week

-8.45%

1 Month

-12.98%

3 Month

-33.40%

6 Month

+11.17%

1 Year

+19.23%

2 Year

-41.24%

5 Year

-7.59%

Profile

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.

DYN Stock Summary

Dyne Therapeutics, Inc. Common Stock (NASDAQ:DYN) stock price today is $14.76, and today's volume is 2,592,893. DYN is down -2.895% today. The 30 day average volume is 1,936,146. DYN market cap is 2.43B with 164,652,236 shares outstanding.